Anti-Botnet Market is Black Eye for AV Industry
alternative coup writes "eWEEK is running a story on the emergence of an anti-botnet market to fill a perceived need for software to deal with botnet-related malware (Trojans, keyloggers, rootkits, etc.). The article characterizes this as 'another black eye' for the existing anti-virus industry — asking consumers to pay twice for protection from things that anti-malware suites are missing. Venture capital money is flowing to these anti-bot products, an implicit statement that the AV giants are not doing their jobs. 'For companies such as Symantec, which sells the Sana-powered Norton AntiBot and anti-malware subscriptions, it's a nickel-and-dime situation. Symantec officials say Norton AntiBot is for a specialized, technical market segment looking for high-end tools to deal with botnets, but [Andrew Jaquith, an analyst with The Yankee Group] said it's a case of anti-malware companies double-dipping.'"
Yep, you're no biologist, and even less of an immunologist. You need to read up on antibodies. Now, part of the immune system does work on heuristics, but a big part of it is all the antibodies running around your body as a "chemical lookup table", but one with a massively parallel seek mechanism.
Laissez lire, et laissez danser; ces deux amusements ne feront jamais de mal au monde. - Voltaire